NCT03071406 2026-03-11
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
45 trialsNCT04526730 2026-02-20
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT05321784 2025-12-29
At-Home Dermoscopy Artificial Intelligence
OHSU Knight Cancer Institute
Phase NA Terminated
NCT01701674 2025-12-19
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03509467 2025-12-19
Using MC1R Genotype to Impact Melanoma Risk Behavior
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00866684 2025-03-14
PROSKIN
Charite University, Berlin, Germany
Phase 4 Terminated
NCT05618912 2024-12-11
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Indiana University
Phase NA Completed
NCT03130569 2024-12-05
SOMBRA
University of New Mexico
Phase NA Completed
NCT05736224 2024-11-27
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Yale University
Phase 1 Completed
NCT03714828 2024-10-09
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
University of Arizona
Phase 2 Completed
NCT04411810 2024-04-08
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer
NYU Langone Health
Phase NA Completed
NCT02324608 2023-12-20
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Rutgers, The State University of New Jersey
Phase NA Completed
NCT03344796 2023-07-27
UV Exposure Assessed With Wearable Sensor and Sun Protection
Northwestern University
Phase NA Completed
NCT02036476 2023-05-09
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT02032810 2023-01-20
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00520299 2022-10-25
Study of ADI-PEG 20 in Patients With Advanced Melanoma
Ludwig Institute for Cancer Research
Phase 1/2 Completed
NCT02218164 2022-10-07
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT01459666 2022-05-26
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
University Hospitals Cleveland Medical Center
Phase 4 Terminated
NCT03834974 2022-01-03
Social Media Indoor Tanning Study
University of Connecticut
Phase NA Completed
NCT01835626 2021-05-03
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
University of California, San Francisco
Phase 2 Completed
NCT02130297 2021-04-19
Post Excision/Mohs Scar Laser Resurfacing
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT02878382 2020-08-04
PDT
University of Sao Paulo
Phase NA Completed
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT02705352 2020-03-09
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
Massachusetts Eye and Ear Infirmary
Phase 2 Completed
NCT03315286 2019-12-18
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
Weill Medical College of Cornell University
Phase NA Completed
NCT00254397 2019-10-16
Melanoma Vaccine With Peptides and Leuprolide
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03237013 2019-07-05
Strategies to Promote Skin Health
San Diego State University
Phase NA Completed
NCT02303041 2019-01-29
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Stanford University
Phase 2 Terminated
NCT01791894 2018-06-08
ATO
Stanford University
Phase 1/2 Completed
NCT01823679 2018-04-12
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Stanford University
Phase 2 Terminated
NCT01079741 2018-02-13
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT00847522 2017-12-20
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma
University of Utah
Phase 1/2 Completed
NCT00715793 2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2 Completed
NCT01059305 2017-04-04
Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01508013 2016-06-02
iSTART
East Tennessee State University
Phase NA Completed
NCT01425749 2016-04-04
Mel55
University of Virginia
Phase EARLY_PHASE1 Completed
NCT00619060 2016-03-10
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
University of Arizona
Phase 1 Completed
NCT00588341 2016-02-01
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01474551 2015-11-18
Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT00885534 2015-05-06
Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00054691 2015-03-13
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00836342 2012-07-25
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
Massachusetts General Hospital
Completed
NCT00535769 2012-07-20
Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT00578214 2012-02-09
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Mayo Clinic
Phase NA Completed
NCT00765193 2010-04-15
TBSE
Medical University of Graz
Phase NA Completed